Atlas Trials

An Open-Label Pharmacokinetic Study for Patients With Actinic Keratosis on the Upper Extremities or the Face

Clinical trial NCT07729579 · RECRUITING

Trial details

NCT number
NCT07729579
Sponsor
Sun Pharmaceutical Industries Limited
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Actinic Keratosis (AK)
Start date
2026-08-04
Primary completion
2026-12-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.